BTEC
EquitiesUSThematicAccumulating
iShares Nasdaq US Biotechnology UCITS ETF
Nasdaq US biotechnology in one product: drug innovation with high volatility.
Key facts
- ISIN
- IE00BYXG2H39
- Provider
- iShares
- Index
- Nasdaq Biotechnology
- TER (annual cost)
- 0.35%
- Replication
- Physical (sampling)
- Distributions
- Accumulating
- Domicile
- Ireland
- Base currency
- USD
- Launch year
- 2017
- Fund size (approx.)
- ~€1bn
Listings
| Exchange | Ticker |
|---|---|
| Xetra | 2B70 |
| London Stock Exchange | BTEC |
| SIX Swiss Exchange | BTEC |
Related articles from the blog
Dollar Cost Averaging (DCA)ETFs
ETFs or stocks: which strategy suits you?
A guide for investors seeking stability, opportunities or both.
15 min read
Dollar Cost Averaging (DCA)ETFs
How to build a resilient portfolio
For investors who want to build something stable, simple and rewarding over the long term.
18 min read
Data as of September 2026, refreshed periodically. This content is for information only and is not investment advice or a recommendation. Verify the official documents (KID/prospectus) with the provider before any decision.